Adam Morgenthaler

Adam Morgenthaler has over 12 years of experience in the engineering field. In 2021, they began working as a Capital Projects Lead at Wildtype. From 2018 to 2021, they worked as a Process Development Engineer at Gritstone Oncology. In 2017, they were a Process Engineer (Contract through ADVENT Engineering) at BioMarin Pharmaceutical Inc. and an ASME BPE System Design Subcommittee Member at ASME (The American Society of Mechanical Engineers). From 2014 to 2017, they were an Engineering Consultant (Contract through ADVENT Engineering) at Bayer. From 2012 to 2014, they were an Engineering Consultant (Contract through ADVENT Engineering) at Bayer. From 2009 to 2012, they were a Process Engineer at ADVENT Engineering. From 2010 to 2017, they were a Member at ASME BPE. From 2013 to 2017, they conducted research at UC Berkeley, focusing on understanding the cell signaling pathways that contribute to loss of cognitive function in the hippocampus and loss of regenerative capacity in muscles.

Adam Morgenthaler attended the University of Colorado Boulder from 2003 to 2008, where they earned a Bachelor's degree in Chemical Engineering, a Minor in Business Administration from the Leeds School of Business, and a Minor in Biochemistry.